Fifth disease: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (7 intermediate revisions by 4 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Fifth disease}} | |||
{{About1|Parvovirus B19}} | |||
'''For patient information click [[{{PAGENAME}} (patient information)|here]]''' | '''For patient information click [[{{PAGENAME}} (patient information)|here]]''' | ||
{{CMG}}; '''Associate Editor-In-Chief:''' {{CZ}}{{F.Z}} | |||
{{CMG}}; '''Associate Editor-In-Chief:''' {{CZ}} | |||
{{SK}} | {{SK}} Erythema infectiosum; parvovirus B19 infection; slapped cheek syndrome; human parvovirus B19 | ||
==[[Fifth disease overview|Overview]]== | ==[[Fifth disease overview|Overview]]== | ||
| Line 26: | Line 28: | ||
==Diagnosis== | ==Diagnosis== | ||
[[Fifth disease history and symptoms|History and Symptoms]] | [[Fifth disease physical examination|Physical Examination]] | [[Fifth disease laboratory findings|Laboratory Findings | [[Fifth disease history and symptoms|History and Symptoms]] | [[Fifth disease physical examination|Physical Examination]] | [[Fifth disease laboratory findings|Laboratory Findings]] | ||
==Treatment== | ==Treatment== | ||
[[Fifth disease medical therapy|Medical Therapy]] | [[Fifth disease primary prevention|Primary Prevention]] | [[Fifth disease cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Fifth disease future or investigational therapies|Future or Investigational Therapies]] | [[Fifth disease medical therapy|Medical Therapy]] | [[Fifth disease primary prevention|Primary Prevention]] | [[Fifth disease cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Fifth disease future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | ==Case Studies== | ||
[[Fifth disease case study one|Case #1]] | [[Fifth disease case study one|Case #1]] | ||
==External links== | ==External links== | ||
* [http://www.cdc.gov/ncidod/diseases/parvovirus/B19.htm CDC] | * [http://www.cdc.gov/ncidod/diseases/parvovirus/B19.htm CDC] | ||
| Line 53: | Line 50: | ||
[[Category:Viral diseases]] | [[Category:Viral diseases]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
Latest revision as of 23:14, 22 July 2021
|
Fifth disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Fifth disease On the Web |
|
American Roentgen Ray Society Images of Fifth disease |
This page is about clinical aspects of the disease. For microbiologic aspects of the causative organism(s), see Parvovirus B19.
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]Fizza Zulfiqar, MD[3]
Synonyms and keywords: Erythema infectiosum; parvovirus B19 infection; slapped cheek syndrome; human parvovirus B19
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Fifth Disease from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings
Treatment
Medical Therapy | Primary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies